Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quanterix Corporation (QTRX)
NASDAQ:QTRX
QTRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.49 - $29.70
Previous CloseN/A
Volume125.22K
Average Volume (3M)895.17K
Market Cap
$292.01M
Enterprise Value$243.27M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.61
Next Earnings
Mar 17, 2025EPS Estimate
-0.26Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.94
Shares Outstanding38,524,326
10 Day Avg. Volume605,288
30 Day Avg. Volume895,169
Standard Deviation0.18
R-Squared0.15
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.26
Price to Cash Flow (P/CF)-13.10
P/FCF Ratio0.00
Enterprise Value/Market Cap0.83
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.44
Enterprise Value/Ebitda-5.62
Forecast
1Y Price Target
$19.67Price Target Upside160.53% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Quanterix News
PremiumCompany Announcements
Quanterix Announces Merger with Akoya Biosciences
PremiumCompany Announcements
Quanterix Merges with Akoya for Enhanced Biomarker Solutions
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceQTRX beat revenue expectations in preliminary 3Q results while reiterating their $134-138M FY24 revenue guidance.
Market OpportunityThe $9 billion Alzheimer's diagnostics market remains a key source of upside for Quanterix.
Strategic GrowthThe acquisition strengthens QTRX position in the oncology and immunology end-markets with translational research offerings.
Bears Say
Cash FlowCash burn was higher than guided, implying Quanterix burned more than their $25-30 million guide.
Competitive ConcernsConcerns about competition from companies like Alamar have been a driver of weakness for Quanterix.
Regulatory And Market ChallengesTimeline updates suggest FDA and Medicare coverage for the multi-marker test could push into 2026, later than previously expected.
---
Ownership Overview
7.37% Insiders
21.58% Mutual Funds
31.28% Other Institutional Investors
27.63% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QTRX FAQ
What was Quanterix Corporation’s price range in the past 12 months?
Quanterix Corporation lowest stock price was $7.49 and its highest was $29.70 in the past 12 months.
What is Quanterix Corporation’s market cap?
Quanterix Corporation’s market cap is $292.01M.
When is Quanterix Corporation’s upcoming earnings report date?
Quanterix Corporation’s upcoming earnings report date is Mar 17, 2025 which is in 23 days.
How were Quanterix Corporation’s earnings last quarter?
Quanterix Corporation released its earnings results on Nov 12, 2024. The company reported -$0.219 earnings per share for the quarter, beating the consensus estimate of -$0.244 by $0.025.
Is Quanterix Corporation overvalued?
According to Wall Street analysts Quanterix Corporation’s price is currently Undervalued.
Does Quanterix Corporation pay dividends?
Quanterix Corporation does not currently pay dividends.
What is Quanterix Corporation’s EPS estimate?
Quanterix Corporation’s EPS estimate is -0.26.
How many shares outstanding does Quanterix Corporation have?
Quanterix Corporation has 38,524,326 shares outstanding.
What happened to Quanterix Corporation’s price movement after its last earnings report?
Quanterix Corporation reported an EPS of -$0.219 in its last earnings report, beating expectations of -$0.244. Following the earnings report the stock price went down -18.26%.
Which hedge fund is a major shareholder of Quanterix Corporation?
Currently, no hedge funds are holding shares in QTRX
---
Quanterix Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.67 (160.53% Upside)
$19.67 (160.53% Upside)
Hedge Fund Trend
Decreased
By 587.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-70.92%
12-Months-Change
Fundamentals
Return on Equity
-10.32%
Trailing 12-Months
Asset Growth
-4.20%
Trailing 12-Months
Company Description
Quanterix Corporation
Quanterix Corp. is a life sciences company, which develops ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Lexington, MA.
---
QTRX Company Deck
---
QTRX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlights Quanterix's consistent revenue growth and strategic advancements in Alzheimer's diagnostics, despite challenges with instrument sales and financial restatements. The company's strong liquidity position and expansion in product offerings reinforce a positive outlook.Read More>---
QTRX Stock 12 Month Forecast
Average Price Target
$19.67
▲(160.53% Upside)
Technical Analysis
Best Analysts Covering QTRX
1 Year
1 Year Success Rate
4/18 ratings generated profit
1 Year Average Return
-29.57%
reiterated a buy rating 2 months ago
Copying Sung Ji Nam's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -29.57% per trade.
---